Next, to dissect the mechanism by which AR modulates NF-κB → CXCL5 signaling, we focused on the PI3K/AKT pathway, as previous studies have demonstrated that PI3K/AKT signaling is aberrantly activated in many cancers, including RCC23, 24, 25, 26. Here, CXCL5 is linked to cancer.